Glucose uptake in the chronically dysfunctional but viable myocardium

Circulation

Volumn 93, Issue 9, 1996, Pages 1658-1666

  Mäki, Maija ^a,d   Luotolahti, Matti ^a   Nuutila, Pirjo ^a   Iida, Hidehiro ^b   Voipio Pulkki, Liisa Maria ^a   Ruotsalainen, Ulla ^a   Haaparanta, Merja ^a   Solin, Olof ^c   Hartiala, Jaakko ^a   Härkönen, Risto ^a   Knuuti, Juhani ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

^c ÅBO AKADEMI UNIVERSITY   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

blood flow; coronary disease; glucose; insulin; myocardium

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HEART INFARCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REVASCULARIZATION; HUMAN; INSULIN RELEASE; MALE; PRIORITY JOURNAL;

EID: 9244230649     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.9.1658     Document Type: Article

References (47)

1. Randle P, Garland P, Hales C, Newsholme E. The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785-789.
2. Taegtmeyer H. Energy metabolism of the heart: from basic concepts to clinical applications. Curr Probl Cardiol. 1994;19:62-113.
3. Opie L, Owen P, Riemersma R. Relative rates of oxidation of glucose and free fatty acids by ischaemic and non-ischaemic myocardium after coronary artery ligation in the dog. Eur J Clin Invest. 1973;3:419-435.
4. Liedtke J. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis. 1981;23:321-336.
5. Opie L. Effects of regional ischemia on metabolism of glucose and fatty acids: relative rates of aerobic and anaerobic energy production during myocardial infarction and comparison with effects of anoxia. Circ Res. 1976;38(suppl I):52-68.
6. Opie L. Hypothesis: glycolytic rates control cell viability in ischemia. J Appl Cardiol. 1988;3:407-414.
7. Takahashi N, Tamaki N, Kawamoto M, Yonekura Y, Magata Y, Nohara R, Sasayama S, Konishi J, Yamamoto K, Ishii Y. Glucose metabolism in relation to perfusion in patients with ischaemic heart disease. Eur J Nucl Med. 1994;21:292-296.
8. Gewirtz H, Fischman A, Abraham S, Gilson M, Strauss W, Alpert N. Positron emission tomographic measurement of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol 1994;23:851-859.
9. Oliver M, Opie L. Effects of glucose and fatty acids on myocardial ischemia and arrhythmias. Lancet. 1994;343:155-158.
10. Braunwald E, Kloner RA. The stunned myocardium: prolonged postischemic ventricular dysfunction. Circulation. 1982;66: 1146-1149.
11. Rahimtoola S. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation. 1985;72(suppl V):V-123-V-135.
12. 18F-deoxyglucose. J Nucl Med. 1989;30:359-366.
13. 18F-labeled fluorodeoxyglucose, and N-13 ammonia. Circulation 1983;67:766-778.
14. Schelbert H, Buxton D. Insights into coronary artery disease gained from metabolic imaging. Circulation. 1988;78:496-505.
15. Camici P, Araujo L, Spinks T, Lammertsma A, Jones T, Maseri A. Myocardial glucose utilization in ischaemic heart disease: preliminary results with F18-fluorodeoxyglucose and positron emission tomography. Eur Heart J. 1986;7(suppl C):19-23.
16. Kalff V, Schwaiger M, Nguyen N, McClanahan T, Gallagher K. The relationship between myocardial blood flow and glucose uptake in ischemic canine myocardium determined with fluorine-18-deoxyglucose. J Nucl Med. 1992;33:1346-1353.
17. DeFronzo R, Tobin J, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
18. Nuutila P, Koivisto V, Knuuti J, Ruotsalainen U, Teräs M, Haaparanta M, Bergman J, Solin O, Voipio-Pulkki L-M, Wegelius U, Yki-Järvinen H. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest. 1992;89:1767-1774.
19. Knuuti J, Nuutila P, Ruotsalainen U, Saraste M, Härkönen R, Ahonen A, Hartiala J, Teräs M, Haaparanta M, Wegelius U, Haapanen A, Hartiala J, Voipio-Pulkki L-M. Euglycemic hyperin-sulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med. 1992;33:1255-1262.
20. Clark J, Crouzel C, Meyer G, Strijckmans K. Current methodology for oxygen-15 production for clinical use. Appl Radiat Isot. 1987;38: 597-600.
21. Crouzel C, Clark J, Brihaye C, Långström B, Lemaire C, Meyer G, Nebeling B, Stone-Elander S. Radiochemistry automation for PET. In: Stöcklin G, Pike V, eds. Radiopharmaceuticals for Positron Emission Tomography. Dordrecht, Netherlands: Kluwer Academic Publishers; 1993:45-90.
22. 18F]fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 1986;27:235-238.
23. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple time uptake data: generalizations. J Cereb Blood Flow Metab. 1985;5:584-590.
24. Ratib O, Phelps ME, Huang S-C, Henze E, Selin CE, Schelbert HR. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med. 1982;23:577-586.
25. Krivokapich J, Huang S, Phelps M, Barrio J, Watanabe C, Selin C, Shine K. Estimation of rabbit myocardial metabolic rate for glucose using fluorodeoxyglucose. Am J Physiol. 1982;243:H884-H895.
26. Krivokapich J, Huang S, Selin C, Phelps M. Fluorodeoxyglucose rate constants, lumped constant, and glucose metabolic rate in rabbit heart. Am J Physiol. 1987;252:H777-H787.
27. 15O and dynamic positron-emission tomography: strategy for quantification in relation to the partial-volume effect. Circulation. 1988;78: 104-115.
28. Iida H, Rhodes C, de Silva R, Yamamoto Y, Jones T, Araujo L. Myocardial tissue fraction: correction for partial volume effects and measure of tissue viability. J Nucl Med. 1991;32:2169-2175.
29. Iida H, Takahashi A, Tamura Y, Ono Y, Lammertsma A. Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. J Nucl Med. 1995;36:78-85.
30. Iida H, Rhodes C, de Silva R, Araujo L, Bloomfield P, Lammertsma A, Jones T. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med. 1992;33:1669-1677.
31. Gropler R, Siegel B, Lee K, Moerlein S, Perry D, Bergmann S, Geltmart E. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med. 1990; 31:1749-1756.
32. Ferrannini E, Santoro D, Bonadonna R, Natali A, Parodi O, Camici P. Metabolic and hemodynamic effects of insulin on human hearts. Am J Physiol. 1993;264:E308-E315.
33. Vanoverschelde J, Wijns W, Depre C, Essamri B, Heyndrickx G, Borgers M, Bol A, Melin J. Mechanisms of chronic regional post-ischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation. 1993; 87:1513-1523.
34. Schiller N, Shah P, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman N, Tajik A. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358-367.
35. Kerber R, Litchfield R. Postoperative abnormalities of interventricular septal motion: two-dimensional and M-mode echocardiographic correlations. Am Heart J. 1982;104:263-268.
36. Kadish A, Little R, Sternberg J. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem. 1968;14:116-131.
37. Marbach E, Weil M. Rapid enzymatic measurement of blood lactate and pyruvate. Clin Chem. 1967;13:314-325.
38. 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers. Life Sci. 1991;49:75-84.
39. Fudo T, Kambara H, Hashimoto T, Hayashi M, Nohara R, Tamaki N, Yonekura Y, Senda M, Konishi J, Kawai C. F-18 deoxyglucose and stress N-13 ammonia positron emission tomography in anterior wall healed myocardial infarction. Am J Cardiol. 1988;61:1191-1197.
40. Tamaki N, Ohtani H, Yamashita K, Magata Y, Yonekura Y, Nohara R, Kambara H, Kawai C, Hirata K, Ban T, Konishi J. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med. 1991;32:673-678.
41. Marinho N, Keogh B, Costa D, Ell P, Lammertsma A, Camici P. Hibernating myocardium: is it really due to chronic underperfusion? Circulation. 1994;90(suppl I):I-314. Abstract.
42. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 1986;314: 884-888.
43. Nuutila P, Knuuti J, Raitakari M, Ruotsalainen U, Teräs M, Voipio-Pulkki L-M, Haaparanta M, Solin O, Wegelius U, Yki-Järvinen H. Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans. Am J Physiol. 1994;267: E941-E946.
44. Knuuti J, Mäki M, Yki-Järvinen H, Voipio-Pulkki L-M, Härkönen R, Haaparanta M, Nuutila P. The effect of insulin and FFA on myocardial glucose uptake. J Mol Cell Cardiol. 1995;27:1359-1367.
45. Camici P, Ferrannini E, Opie L. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis. 1989;32: 217-238.
46. Medical Research Council. Clinical trial of potassium-glucose-insulin (PGI) treatment in myocardial infarction. Lancet. 1968;2: 1355-1360.
47. 18F] 2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. Circulation. 1995; 91:2435-2444.